Bridget R Durkin, MD, MBE
Assistant Professor of Clinical Medicine (General Internal Medicine)
Medical Director, Addiction Medicine Consult Team, Hospital of the University of Pennsylvania
Co-Chair, Opioid Task Force, University of Pennsylvania Health System
Department: Medicine
Contact information
Hospital of the University of Pennsylvania
3400 Spruce Street
White Building, 2nd Floor
Philadelphia, PA 19104
3400 Spruce Street
White Building, 2nd Floor
Philadelphia, PA 19104
Office: 2674020702
Education:
AB (Classics)
Princeton University, 2007.
MD
Perelman School of Medicine, University of Pennsylvania, 2018.
MBE (Bioethics)
Perelman School of Medicine, University of Pennsylvania, 2018.
Permanent linkAB (Classics)
Princeton University, 2007.
MD
Perelman School of Medicine, University of Pennsylvania, 2018.
MBE (Bioethics)
Perelman School of Medicine, University of Pennsylvania, 2018.
Description of Clinical Expertise
Substance Use DisorderMedical Ethics
Symptom Management in Serious Illness
Polysubstance Withdrawal
Medetomidine Withdrawal
Selected Publications
Tyler G. Boyce, Ashish P. Thakrar, MD, MS, Bridget R. Durkin, MD, MBE, Emily R. Casey, PharmD, BCPMP, Lin Xu, MS, Margaret Lowenstein, MD,MPhil, MSHP: "Trends in Hospital and Intensive Care Unit Admissions for Medetomidine Withdrawal" in review 2026.Ann A. Soliman, MD, Jennifer M. Olenik, MD, Alana Sagin, MD, MSEd, Bridget Durkin, MD, MBE: Qualitative Study of Preclinical Medical Student Reflections on Required Palliative Care Experience Journal of Pain and Symptom Management 70(3): 287-294, September 2025.
Samantha Huo, MD; Kory London, MD; Lauren Murphy, MD; Emily Casey, PharmD; Philip Durney, MD; Maya Arora; Rita McKeever, MD; Abriana Tasillo, MD; Dennis Goodstein, PharmD; Brendan Hart, MD, PhD; Jeanmarie Perrone, MD: "Notes from the Field: Suspected Medetomidine Withdrawal Syndrome Among Fentanyl-Exposed Patients — Philadelphia, Pennsylvania, September 2024–January 2025" Morbidity and Mortality Weekly Report(74), 266-268, May 2025.
Bridget Durkin: “Managing the Clinical and Ethical Challenges of Naloxone in Hospitalized Palliative Care Patients.” Annual Assembly of Hospice & Palliative Care. Poster Presentation. Montreal, Canada Mar 2023.
Maley JH, et al: “Six-Month Impairment in Cognition, Mental Health, and Physical Function Following COVID-19-Associated Respiratory Failure.” Critical Care Exploration 4(4), Mar 2022.